Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Lamph

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Breast Cancer Research and Treatment|January 1, 1996
The efficacy of 9-cis retinoic acid in experimental models of cancerM M Gottardis, W W Lamph, D R Shalinsky, et al.
Ciba Foundation Symposium|January 1, 1990
fos-jun conspiracy: implications for the cellI M Verma, L J Ransone, J Visvader, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1989
fos and jun interaction: the role of the leucine zipperL J Ransone, J Visvader, W W Lamph, et al.
Princess Takamatsu Symposia|January 1, 1989
fos-jun Conspiracy: implications for the cellI M Verma, L J Ransone, J Visvader, et al.
Cancer Research|November 21, 1998
Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expressionA Rosenauer, C Nervi, K Davison, et al.
Cancer Research|February 11, 1998
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinomaE D Bischoff, M M Gottardis, T E Moon, et al.
British Journal of Cancer|February 24, 2006
A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumoursW-C Yen, R Y Prudente, M R Corpuz, et al.
Molecular and Cellular Biology|April 1, 1990
mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response elementL B Ivashkiv, H C Liou, C J Kara, et al.
Cancer Research|December 15, 1996
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligandM M Gottardis, E D Bischoff, M A Shirley, et al.
Cancer Research|August 2, 2001
Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell linesJ I Song, M N Lango, J D Hwang, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Breast Cancer Research and Treatment|January 1, 1996
The efficacy of 9-cis retinoic acid in experimental models of cancerM M Gottardis, W W Lamph, D R Shalinsky, et al.
Ciba Foundation Symposium|January 1, 1990
fos-jun conspiracy: implications for the cellI M Verma, L J Ransone, J Visvader, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1989
fos and jun interaction: the role of the leucine zipperL J Ransone, J Visvader, W W Lamph, et al.
Princess Takamatsu Symposia|January 1, 1989
fos-jun Conspiracy: implications for the cellI M Verma, L J Ransone, J Visvader, et al.
Cancer Research|November 21, 1998
Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expressionA Rosenauer, C Nervi, K Davison, et al.
Cancer Research|February 11, 1998
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinomaE D Bischoff, M M Gottardis, T E Moon, et al.
British Journal of Cancer|February 24, 2006
A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumoursW-C Yen, R Y Prudente, M R Corpuz, et al.
Molecular and Cellular Biology|April 1, 1990
mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response elementL B Ivashkiv, H C Liou, C J Kara, et al.
Cancer Research|December 15, 1996
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligandM M Gottardis, E D Bischoff, M A Shirley, et al.
Cancer Research|August 2, 2001
Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell linesJ I Song, M N Lango, J D Hwang, et al.
Pageof 4